RAPT Therapeutics (RAPT) Short Interest Ratio & Short Volume → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free RAPT Stock Alerts Notice: Trading of RAPT Therapeutics halted at 10:00 AM EST due to "LULD pause". $4.80 -3.18 (-39.85%) (As of 03:04 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability RAPT Therapeutics Short Interest DataCurrent Short Volume3,180,000 sharesPrevious Short Volume2,980,000 sharesChange Vs. Previous Month+6.71%Dollar Volume Sold Short$27.16 millionShort Interest Ratio / Days to Cover2.4Last Record DateApril 15, 2024Outstanding Shares34,800,000 sharesPercentage of Shares Shorted9.14%Today's Trading Volume4,268,243 sharesAverage Trading Volume1,135,937 sharesToday's Volume Vs. Average376% Short Selling RAPT Therapeutics ? Sign up to receive the latest short interest report for RAPT Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRAPT Short Interest Over TimeRAPT Days to Cover Over TimeRAPT Percentage of Float Shorted Over Time Ad The Oxford Club348 million Americans lives to END as we know it?348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today...To see my free research, simply click here now. RAPT Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,180,000 shares $27.16 million +6.7%N/A2.4 $8.54 3/31/20242,980,000 shares $26.76 million -9.7%N/A2.4 $8.98 3/15/20243,300,000 shares $27.95 million +32.5%N/A2.7 $8.47 2/29/20242,490,000 shares $21.34 million -29.1%N/A2.2 $8.57 2/15/20243,510,000 shares $89.65 million -11.1%N/A3.7 $25.54 1/31/20243,950,000 shares $97.76 million No ChangeN/A9.2 $24.75 Get the Latest News and Ratings for RAPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RAPT Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,950,000 shares $95.12 million -4.1%N/A9.2 $24.08 12/31/20234,120,000 shares $102.38 million -13.5%N/A9.6 $24.85 12/15/20234,760,000 shares $93.77 million -0.6%N/A11.2 $19.70 11/30/20234,790,000 shares $69.55 million +12.4%N/A12.4 $14.52 11/15/20234,260,000 shares $51.21 million +6.8%N/A11.7 $12.02 10/31/20233,990,000 shares $52.47 million -6.6%N/A11 $13.15 10/15/20234,270,000 shares $52.26 million -0.9%N/A13.3 $12.24 9/30/20234,310,000 shares $71.63 million +5.1%N/A15.3 $16.62 9/15/20234,100,000 shares $79.95 million +1.2%N/A15 $19.50 8/31/20234,050,000 shares $77.36 million +2.0%N/A13.9 $19.10 8/15/20233,970,000 shares $85.08 million +1.0%N/A13.7 $21.43 7/31/20233,930,000 shares $93.93 million +0.8%N/A14.1 $23.90 7/15/20233,900,000 shares $80.77 million +1.3%N/A13.3 $20.71 6/30/20233,850,000 shares $72.00 million +10.3%N/A11.9 $18.70 6/15/20233,490,000 shares $75.42 million +12.2%N/A9.7 $21.61 5/31/20233,110,000 shares $62.29 million +6.5%N/A7.5 $20.03 5/15/20232,920,000 shares $62.31 million +2.1%N/A6.5 $21.34 4/30/20232,860,000 shares $52.05 million +3.3%N/A6.1 $18.20 4/15/20232,770,000 shares $46.45 million +1.8%N/A5.7 $16.77 3/31/20232,720,000 shares $49.91 million +3.8%N/A5.5 $18.35 3/15/20232,620,000 shares $49.91 million -14.1%N/A5.6 $19.05 2/28/20233,050,000 shares $89.82 million -10.6%N/A7 $29.45 2/15/20233,410,000 shares $97.66 million +6.6%N/A8.2 $28.64 1/31/20233,200,000 shares $92.96 million +2.9%N/A7.5 $29.05 1/15/20233,110,000 shares $81.79 million +2.3%N/A7.8 $26.30 12/30/20223,040,000 shares $60.19 million +17.4%N/A8.4 $19.80 12/15/20222,590,000 shares $46.34 million +3.2%N/A7.4 $17.89 11/30/20222,510,000 shares $44.38 million -9.4%N/A7.1 $17.68 11/15/20222,770,000 shares $65.29 million -9.5%N/A8.3 $23.57 10/31/20223,060,000 shares $66.77 million +6.3%13.3%9.7 $21.82 10/15/20222,880,000 shares $60.16 million +1.1%12.9%9.2 $20.89 9/30/20222,850,000 shares $68.57 million +7.6%12.8%9.4 $24.06 9/15/20222,650,000 shares $70.30 million -3.3%11.9%8.5 $26.53 8/31/20222,740,000 shares $73.19 million +8.7%12.3%8.6 $26.71The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide RAPT Short Interest - Frequently Asked Questions What is RAPT Therapeutics' current short interest? Short interest is the volume of RAPT Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 3,180,000 shares of RAPT short. Learn More on RAPT Therapeutics' current short interest. What is a good short interest ratio for RAPT Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RAPT shares currently have a short interest ratio of 2.0. Learn More on RAPT Therapeutics's short interest ratio. Is RAPT Therapeutics' short interest increasing or decreasing? RAPT Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 3,180,000 shares, an increase of 6.7% from the previous total of 2,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does RAPT Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to RAPT Therapeutics: XBiotech Inc. (3.40%), Eliem Therapeutics, Inc. (3.26%), Xeris Biopharma Holdings, Inc. (6.03%), Inozyme Pharma, Inc. (7.66%), CytomX Therapeutics, Inc. (5.27%), Enanta Pharmaceuticals, Inc. (13.94%), XOMA Co. (2.42%), Nektar Therapeutics (1.75%), Verastem, Inc. (3.94%), Akebia Therapeutics, Inc. (6.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short RAPT Therapeutics stock? Short selling RAPT is an investing strategy that aims to generate trading profit from RAPT Therapeutics as its price is falling. RAPT shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RAPT Therapeutics? A short squeeze for RAPT Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RAPT, which in turn drives the price of the stock up even further. How often is RAPT Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RAPT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: XBiotech Short Squeeze Eliem Therapeutics Short Squeeze Xeris Biopharma Short Squeeze Inozyme Pharma Short Squeeze CytomX Therapeutics Short Squeeze Enanta Pharmaceuticals Short Squeeze XOMA Short Squeeze Nektar Therapeutics Short Squeeze Verastem Short Squeeze Akebia Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RAPT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThings Are Not Normal in America – Here’s What to DoStansberry Research1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange